毒素诱导的炎:在马塞特肌肉注射后的一种术后并发症
Nadav Grinberg1, Sara Whitefield2, Shlomi Kleinman3
1Trainee, Department of Otolaryngology, Head and Neck Surgery and Maxillofacial Surgery, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel; Physician, "Bina" Program, Medical Corps (IDF) and Faculty of Dental Medicine, Hebrew University, Jerusalem, Israel.
概括
毒素 (BTX) 注射用于乳症可能会导致罕见的唾液腺问题,如炎. 本案例研究和文献综述探讨了BTX相关的唾液腺并发症的潜在原因和预防策略.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 神经学 神经学
- 整形外科 整形外科 整形外科
背景情况:
- 毒素 (BTX) 注射是一种常见的治疗方法.
- 在文献中缺乏关于BTX治疗后可能出现的唾液腺并发症的信息.
研究的目的:
- 在BTX注射后呈现急性炎的病例,用于按摩肌肉治疗.
- 审查关于BTX诱导的唾液腺并发症的现有文献.
- 探索潜在的病因和预防措施.
主要方法:
- 一个60岁的女性在BTX注射后患有急性炎的病例报告.
- 在PubMed和Embase数据库中进行系统的电子文献搜索.
- 审查和讨论31个相关的文章.
主要成果:
- 在注射BTX到按摩器肌肉后,有罕见的急性炎病例被记录在案.
- 关于BTX相关的唾液腺并发症的确切原因,没有共识.
- 提出的病因因素包括解剖学,生理学,生物学和物理方面的因素.
结论:
- 在肌中注射BTX可能会导致唾液腺并发症,如炎.
- 需要进一步的研究来了解这些并发症的病因.
- 建议推安全的BTX注射实践和加强医疗培训,以尽量减少风险.
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
482
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
482
Skeletal Muscle Relaxants: Adverse Effects
370
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
370
Depolarizing Blockers: Mechanism of Action
1.6K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.6K
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
680
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
680
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
420
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
420


